Children with mild to moderate asthma do not benefit from a common practice of increasing their inhaled steroids at the first signs of an asthma exacerbation, according to clinical trial results ...

Flovent, one of the most commonly prescribed childhood asthma medications, is no longer being manufactured in the United States. GSK, the pharmaceutical company that made it, took if off the ...

Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma.

A new study suggests that many patients aren’t waiting between puffs on their inhalers and may not be deriving the full benefits of the drugs. By Perri Klass, M.D. Asthma is the most common ...

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a ...

Typically, someone given an inhaler is advised to take two puffs during an asthma symptom flare. "A nebulizer treatment is equivalent to about 10 puffs of an inhaler," Blaiss said.